e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Boundless Bio, Inc. - Common Stock
(NQ:
BOLD
)
1.580
-0.050 (-3.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
352,286
Open
1.640
Bid (Size)
1.490 (400)
Ask (Size)
1.660 (1,500)
Prev. Close
1.630
Today's Range
1.570 - 1.649
52wk Range
0.9612 - 1.780
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
April 17, 2026
Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers
From
Boundless Bio, Inc.
Via
GlobeNewswire
Tuesday's session: gap up and gap down stocks
↗
April 14, 2026
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Performance
YTD
+29.5%
+29.5%
1 Month
+35.0%
+35.0%
3 Month
+27.4%
+27.4%
6 Month
+15.3%
+15.3%
1 Year
+11.3%
+11.3%
More News
Read More
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
March 17, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
March 09, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Leerink Global Healthcare Conference
March 04, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 05, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
January 20, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
November 05, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio (BOLD) Q2 R&D Drops 17%
↗
August 05, 2025
Via
The Motley Fool
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
August 05, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 05, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Announces Portfolio Prioritization and Runway Extension
May 23, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
May 09, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
April 03, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
March 27, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Leerink Global Healthcare Conference
February 26, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
February 03, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Announces Pipeline and Leadership Updates
December 12, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Piper Sandler Healthcare Conference
November 25, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
November 07, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
November 05, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Announces Departure of Chief Financial Officer
October 14, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
September 11, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Boundless Bio, Inc. - Common Stock publicly traded?
Yes, Boundless Bio, Inc. - Common Stock is publicly traded.
What exchange does Boundless Bio, Inc. - Common Stock trade on?
Boundless Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Boundless Bio, Inc. - Common Stock?
The ticker symbol for Boundless Bio, Inc. - Common Stock is BOLD on the Nasdaq Stock Market
What is the current price of Boundless Bio, Inc. - Common Stock?
The current price of Boundless Bio, Inc. - Common Stock is 1.580
When was Boundless Bio, Inc. - Common Stock last traded?
The last trade of Boundless Bio, Inc. - Common Stock was at 04/17/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.